| P50 | author | Qian Tao | Q57795670 |
| | Gang Li | Q73825085 |
| | Yibin Kang | Q88721106 |
| P2093 | author name string | Qifeng Yang | |
| | Y Eugene Chin | |
| | Ning Zhang | |
| | Hong Pan | |
| | Jing Hu | |
| | Yufeng Wang | |
| | Jianru Xiao | |
| | Guohong Hu | |
| | Da Fu | |
| | Xiaoqi Pan | |
| | Rong Lei | |
| | Xueqian Zhuang | |
| P2860 | cites work | DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms | Q24297480 |
| | The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration | Q24319183 |
| | Common origin of four diverse families of large eukaryotic DNA viruses | Q24529306 |
| | The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells | Q24537312 |
| | Comprehensive molecular portraits of human breast tumours | Q24630844 |
| | Genes that mediate breast cancer metastasis to the brain | Q24644008 |
| | Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver | Q24645379 |
| | MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer | Q24651422 |
| | Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 |
| | Systematic variation in gene expression patterns in human cancer cell lines | Q28145747 |
| | Smad-dependent and Smad-independent pathways in TGF-beta family signalling | Q28208250 |
| | Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits | Q28237197 |
| | TGFβ signalling in context | Q28275410 |
| | TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4 | Q28275478 |
| | Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK) | Q28392664 |
| | Genes that mediate breast cancer metastasis to lung | Q29547479 |
| | A multigenic program mediating breast cancer metastasis to bone | Q29614308 |
| | RHO-GTPases and cancer | Q29616099 |
| | A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival | Q30473091 |
| | Rho overexpression leads to mitosis-associated detachment of cells from epithelial sheets: a link to the mechanism of cancer dissemination | Q30831570 |
| | Non-consensus GLI binding sites in Hedgehog target gene regulation | Q33523633 |
| | Matrix rigidity induces osteolytic gene expression of metastatic breast cancer cells | Q33749971 |
| | PTHrP induces autocrine/paracrine proliferation of bone tumor cells through inhibition of apoptosis | Q33916140 |
| | Mechanisms of bone metastasis | Q33977526 |
| | Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells | Q34580134 |
| | Protocol for the fast chromatin immunoprecipitation (ChIP) method | Q34615353 |
| | Parathyroid hormone-like hormone (PTHLH) represses decidualization of human uterine fibroblast cells by an autocrine/paracrine mechanism | Q34622470 |
| | Guanosine nucleotides inhibit different syndromes of PTHrP excess caused by human cancers in vivo | Q34825844 |
| | Manipulating the environment of cancer cells in bone: a novel therapeutic approach | Q34826767 |
| | Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study | Q35683537 |
| | Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer | Q36516410 |
| | Bone marrow cells in the 'pre-metastatic niche': within bone and beyond | Q36691234 |
| | Cancer to bone: a fatal attraction | Q36884628 |
| | Role of Rho GTPases in breast cancer | Q36991923 |
| | PTH and PTHrP signaling in osteoblasts | Q37297529 |
| | Roles of TGFbeta in metastasis | Q37339711 |
| | Optimal management of bone metastases in breast cancer patients | Q37355487 |
| | Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis | Q37360238 |
| | ROCK inhibitors as emerging therapeutic candidates for sarcomas | Q37678530 |
| | The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. | Q37830915 |
| | TGF-β in the Bone Microenvironment: Role in Breast Cancer Metastases | Q37900199 |
| | Targeting Rho GTPase signaling for cancer therapy | Q37984123 |
| | Genes associate with abnormal bone cell activity in bone metastasis | Q38019409 |
| | Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. | Q39183046 |
| | Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells | Q39269242 |
| | The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. | Q39411440 |
| | Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone | Q39779365 |
| | MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? | Q39834203 |
| | Transforming growth factor-{beta}-inducible phosphorylation of Smad3 | Q39883712 |
| | The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models | Q40229870 |
| | The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells | Q40248555 |
| | Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells | Q40944816 |
| | Parathyroid hormone-related protein and bone metastases | Q41080338 |
| | Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines | Q42824450 |
| | Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases | Q44723987 |
| | Metastatic patterns in adenocarcinoma | Q46085183 |
| | Synthetic peptides comprising the amino-terminal sequence of a parathyroid hormone-like protein from human malignancies. Binding to parathyroid hormone receptors and activation of adenylate cyclase in bone cells and kidney | Q46517018 |
| | Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. | Q46952761 |
| | Temporally and spatially coordinated roles for Rho, Rac, Cdc42 and their effectors in growth cone guidance by a physiological electric field. | Q51233431 |
| | DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis. | Q52587060 |
| | Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. | Q52594636 |
| | Rho GTPases and their role in organizing the actin cytoskeleton. | Q54612905 |
| | Phosphorylation of vimentin by Rho-associated kinase at a unique amino-terminal site that is specifically phosphorylated during cytokinesis | Q74495110 |
| | Effects of parathyroid hormone like hormone (PTHLH) antagonist, PTHLH(7-34), on fetoplacental development and growth during midgestation in rats | Q81042602 |
| | Fibroblast migration is mediated by CD44-dependent TGF beta activation | Q81043148 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 1646-1659 | |
| P577 | publication date | 2014-03-03 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis | |
| P478 | volume | 124 | |